Delivery Order SPE2DB20D2104-SPE2DB25FMXDJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $3,274.38. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a continuation of the company's pharmaceutical supply relationship with DLA. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $8,972.46 under a firm fixed-price contract structure. This non-set-aside award represents a child delivery order executed against AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Januvia 50 mg tablets (90-count) under a firm fixed-price contract valued at $1,157.76, with an ultimate completion date of July 31, 2025. This non-set-aside award was issued on July 30, 2025, and represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $1,106.86. This non-set-aside delivery order is scheduled for completion by August 11, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located at the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with a ceiling value of $10,411.20 and an ultimate completion date of August 5, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count) under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $6,429.02. This non-set-aside delivery order is scheduled for completion by August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement action supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.46 to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract for delivery to the vendor's corporate headquarters location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,091.46. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Januvia 100 mg tablets in quantities of 1,000 units. The contract is valued at $12,163.38 and carries a firm fixed price structure with an ultimate completion date of August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no set-aside...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXDJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Januvia 50 mg tablets (90-count) with a contract value of $1,262.81. This delivery order operates under a firm fixed-price arrangement with an ultimate completion date of August 4, 2025. The contract was awarded competitively with no set-aside designation and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio with the DLA encompasses a broad range of pharmaceutical products including brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order fulfills the Defense Health Agency's pharmaceutical supply needs through AmerisourceBergen's established prime vendor relationship, which positions the company as a critical component of the Defense Logistics Agency's global pharmaceutical supply chain supporting military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/1/25 |